• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于纳米药物递送的微流体技术。

Microfluidics for Nanomedicine Delivery.

作者信息

Chen Kangfu, Yang Hongfen, Cai Ren

机构信息

Hunan Key Laboratory of Typical Environmental Pollution and Health Hazards, School of Public Health, Hengyang Medical School, University of South China, Hengyang 421001, China.

Department of Biomedical Engineering, Northwestern University, Chicago, Illinois 60611, United States.

出版信息

ACS Biomater Sci Eng. 2025 Feb 10;11(2):774-783. doi: 10.1021/acsbiomaterials.4c02052. Epub 2025 Jan 8.

DOI:10.1021/acsbiomaterials.4c02052
PMID:39772433
Abstract

Nanomedicine is revolutionizing precision medicine, providing targeted, personalized treatment options. Lipid-based nanomedicines offer distinct benefits including high potency, targeted delivery, extended retention in the body, reduced toxicity, and lower required doses. These characteristics make lipid-based nanoparticles ideal for drug delivery in areas such as gene therapy, cancer treatment, and mRNA vaccines. However, traditional bulk synthesis methods for LNPs often produce larger particle sizes, significant polydispersity, and low encapsulation efficiency, which can reduce the therapeutic effectiveness. These issues primarily result from uneven mixing and limited control over particle formation during the synthesis. Microfluidic technology has emerged as a solution, providing precise control over particle size, uniformity, and encapsulation efficiency. In this mini review, we introduce the state-of-the-art microfluidic systems for lipid-based nanoparticle synthesis and functionalization. We include the working principles of different types of microfluidic systems, the use of microfluidic systems for LNP synthesis, cargo encapsulation, and nanomedicine delivery. In the end, we briefly discuss the clinical use of LNPs enabled by microfluidic devices.

摘要

纳米医学正在彻底改变精准医学,提供靶向、个性化的治疗选择。基于脂质的纳米药物具有显著优势,包括高效能、靶向递送、在体内的长时间留存、降低毒性以及较低的所需剂量。这些特性使基于脂质的纳米颗粒成为基因治疗、癌症治疗和mRNA疫苗等领域药物递送的理想选择。然而,传统的脂质纳米颗粒(LNP)批量合成方法通常会产生较大的粒径、显著的多分散性和较低的包封效率,这可能会降低治疗效果。这些问题主要源于合成过程中混合不均匀以及对颗粒形成的控制有限。微流控技术已成为一种解决方案,可对粒径、均匀性和包封效率进行精确控制。在本综述中,我们介绍了用于基于脂质的纳米颗粒合成和功能化的先进微流控系统。我们包括不同类型微流控系统的工作原理、微流控系统在LNP合成、货物包封和纳米药物递送中的应用。最后,我们简要讨论了微流控装置实现的LNP的临床应用。

相似文献

1
Microfluidics for Nanomedicine Delivery.用于纳米药物递送的微流体技术。
ACS Biomater Sci Eng. 2025 Feb 10;11(2):774-783. doi: 10.1021/acsbiomaterials.4c02052. Epub 2025 Jan 8.
2
Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.基于微流控的脂质纳米颗粒粒径控制后处理方法的开发及其在 siRNA 递送中的应用。
ACS Appl Mater Interfaces. 2020 Jul 29;12(30):34011-34020. doi: 10.1021/acsami.0c05489. Epub 2020 Jul 15.
3
Microfluidics: a transformational tool for nanomedicine development and production.微流控技术:纳米医学开发与生产的变革性工具。
J Drug Target. 2016 Nov;24(9):821-835. doi: 10.1080/1061186X.2016.1198354. Epub 2016 Aug 5.
4
Microfluidics for Development of Lipid Nanoparticles: Paving the Way for Nucleic Acids to the Clinic.微流控技术在脂质纳米粒开发中的应用:为核酸药物进入临床铺平道路。
ACS Appl Bio Mater. 2023 Sep 18;6(9):3566-3576. doi: 10.1021/acsabm.1c00732. Epub 2021 Sep 8.
5
Microfluidic synthesis of lipid-based nanoparticles for drug delivery: recent advances and opportunities.用于药物递送的基于脂质的纳米粒子的微流控合成:最新进展和机遇。
Lab Chip. 2024 Feb 27;24(5):1154-1174. doi: 10.1039/d3lc00821e.
6
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform.采用微流控混合平台制备和表征用于基因传递的脂质纳米粒。
J Vis Exp. 2021 Feb 25(168). doi: 10.3791/62226.
7
The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution.微流控混合法制备的脂质纳米粒子的大小和电荷对其淋巴结转移和分布的影响。
Mol Pharm. 2020 Mar 2;17(3):944-953. doi: 10.1021/acs.molpharmaceut.9b01182. Epub 2020 Feb 5.
8
Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems.微流控技术在脂质纳米粒和细胞外囊泡方面的进展及其在药物传递系统中的应用。
Adv Drug Deliv Rev. 2018 Mar 15;128:84-100. doi: 10.1016/j.addr.2018.03.008. Epub 2018 Mar 19.
9
Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications.微流控技术生产用于疫苗应用的载 mRNA 脂质纳米粒。
Expert Opin Drug Deliv. 2022 Oct;19(10):1381-1395. doi: 10.1080/17425247.2022.2135502. Epub 2022 Oct 20.
10
Microfluidics for the Production of Nanomedicines: Considerations for Polymer and Lipid-based Systems.用于生产纳米药物的微流控技术:基于聚合物和脂质系统的考量
Pharm Nanotechnol. 2019;7(6):423-443. doi: 10.2174/2211738507666191019154815.

引用本文的文献

1
Emerging Trends in Microfluidic Biomaterials: From Functional Design to Applications.微流控生物材料的新兴趋势:从功能设计到应用
J Funct Biomater. 2025 May 8;16(5):166. doi: 10.3390/jfb16050166.